Clinical trial

Kidney Alone Versus Islet-After-Kidney in Type 1 Diabetic Kidney Transplant Recipient.

NCT05662267

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

OTHER · Unmapped registry intervention Pancreatic islet transplantation after kidney transplantation Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Kidney Alone Versus Islet-After-Kidney in Type 1 Diabetic Kidney Transplant Recipient.

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2020-03-10

PhaseN/A

Conditions

type1diabetesunresolved

Renal Failureverified · MONDO: kidney failure

End Stage Renal Diseaseverified · MONDO: end stage renal failure

Interventions

Pancreatic islet transplantation after kidney transplantationOTHER

Sponsors & collaborators

University Hospital, Lillelead sponsor

Agence de La Biomédecinecollaborator

Mapped research locations

LilleFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05662267 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.